Koji Yamanaka

22.6k total citations · 3 hit papers
114 papers, 7.5k citations indexed

About

Koji Yamanaka is a scholar working on Neurology, Neurology and Genetics. According to data from OpenAlex, Koji Yamanaka has authored 114 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Neurology, 40 papers in Neurology and 33 papers in Genetics. Recurrent topics in Koji Yamanaka's work include Amyotrophic Lateral Sclerosis Research (65 papers), Neurogenetic and Muscular Disorders Research (33 papers) and Neuroinflammation and Neurodegeneration Mechanisms (28 papers). Koji Yamanaka is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (65 papers), Neurogenetic and Muscular Disorders Research (33 papers) and Neuroinflammation and Neurodegeneration Mechanisms (28 papers). Koji Yamanaka collaborates with scholars based in Japan, United States and India. Koji Yamanaka's co-authors include Don W. Cleveland, Séverine Boillée, Okiru Komine, Finn Ankersen, Christian S. Lobsiger, George Kassiotis, George Kollias, Nancy A. Jenkins, Neal G. Copeland and Kumi Kaneko and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Koji Yamanaka

109 papers receiving 7.4k citations

Hit Papers

Onset and Progression in ... 2002 2026 2010 2018 2006 2008 2002 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koji Yamanaka Japan 42 4.3k 2.9k 2.4k 1.9k 1.3k 114 7.5k
Andrew J. Grierson United Kingdom 33 2.0k 0.5× 2.1k 0.7× 1.1k 0.5× 590 0.3× 765 0.6× 60 4.6k
Zhuohua Zhang China 42 1.1k 0.3× 5.3k 1.8× 119 0.1× 517 0.3× 1.8k 1.4× 89 8.5k
Takashi Sakurai Japan 31 474 0.1× 2.7k 1.0× 157 0.1× 253 0.1× 1.1k 0.8× 177 4.5k
Marcie A. Glicksman United States 35 723 0.2× 2.0k 0.7× 271 0.1× 344 0.2× 679 0.5× 109 4.1k
Frank Gillardon Germany 37 1.5k 0.3× 2.2k 0.8× 166 0.1× 752 0.4× 1.0k 0.8× 98 4.6k
Charles Vanderburg United States 29 949 0.2× 4.3k 1.5× 113 0.0× 725 0.4× 1.3k 1.0× 63 6.8k
Jun‐ichi Satoh Japan 42 727 0.2× 2.3k 0.8× 189 0.1× 1.4k 0.7× 906 0.7× 181 5.3k
Olga Pletniková United States 49 3.5k 0.8× 4.2k 1.5× 577 0.2× 1.3k 0.7× 2.8k 2.1× 84 8.9k
Lee Cyn Ang Canada 34 1.3k 0.3× 1.2k 0.4× 240 0.1× 366 0.2× 656 0.5× 95 3.9k
Toshiki Uchihara Japan 41 2.9k 0.7× 2.0k 0.7× 99 0.0× 1.1k 0.6× 2.1k 1.5× 204 6.1k

Countries citing papers authored by Koji Yamanaka

Since Specialization
Citations

This map shows the geographic impact of Koji Yamanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Yamanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Yamanaka more than expected).

Fields of papers citing papers by Koji Yamanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Yamanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Yamanaka. The network helps show where Koji Yamanaka may publish in the future.

Co-authorship network of co-authors of Koji Yamanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Yamanaka. A scholar is included among the top collaborators of Koji Yamanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Yamanaka. Koji Yamanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujisawa, Haruki, Takashi Watanabe, Okiru Komine, et al.. (2024). Prolonged extracellular low sodium concentrations and subsequent their rapid correction modulate nitric oxide production dependent on NFAT5 in microglia. Free Radical Biology and Medicine. 223. 458–472. 1 indexed citations
2.
Matsudaira, Tatsuyuki, Yusuke Konishi, Shimpei Kawamoto, et al.. (2023). Cellular senescence in white matter microglia is induced during ageing in mice and exacerbates the neuroinflammatory phenotype. Communications Biology. 6(1). 665–665. 43 indexed citations
3.
Sobue, Akira, Okiru Komine, & Koji Yamanaka. (2023). Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease. Inflammation and Regeneration. 43(1). 26–26. 64 indexed citations
4.
Hashimoto, Kei, Seiji Watanabe, Masato Akutsu, et al.. (2023). Intrinsic structural vulnerability in the hydrophobic core induces species-specific aggregation of canine SOD1 with degenerative myelopathy–linked E40K mutation. Journal of Biological Chemistry. 299(6). 104798–104798. 3 indexed citations
5.
Konishi, Hiroyuki, Takayuki Okamoto, Yuichiro Hara, et al.. (2020). Astrocytic phagocytosis is a compensatory mechanism for microglial dysfunction. The EMBO Journal. 39(22). e104464–e104464. 131 indexed citations
6.
Amporndanai, Kangsa, Michael S. Rogers, Seiji Watanabe, et al.. (2020). Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis. EBioMedicine. 59. 102980–102980. 33 indexed citations
7.
Nishino, Kohei, Seiji Watanabe, Shijie Jin, et al.. (2019). Mice deficient in the C-terminal domain of TAR DNA-binding protein 43 develop age-dependent motor dysfunction associated with impaired Notch1−Akt signaling pathway. Acta Neuropathologica Communications. 7(1). 118–118. 19 indexed citations
8.
Komine, Okiru, Hirofumi Yamashita, Noriko Fujimori-Tonou, et al.. (2018). Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes. Cell Death and Differentiation. 25(12). 2130–2146. 48 indexed citations
9.
Tokuda, Eiichi, Itsuki Anzai, Takao Nomura, et al.. (2017). Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis. Molecular Neurodegeneration. 12(1). 2–2. 20 indexed citations
10.
Mitani, Shinji, et al.. (2016). High-Agility, Miniaturized Attitude Control Sensors and Actuators in an All-in-one Module. TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES AEROSPACE TECHNOLOGY JAPAN. 14(ists30). Pd_47–Pd_53. 2 indexed citations
11.
Lašienė, Jūratė, Okiru Komine, Noriko Fujimori-Tonou, et al.. (2016). Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons. Acta Neuropathologica Communications. 4(1). 15–15. 46 indexed citations
12.
Watanabe, Seiji, Hristelina Ilieva, Hiromi Tamada, et al.. (2016). Mitochondria‐associated membrane collapse is a common pathomechanism in SIGMAR 1 ‐ and SOD 1 ‐linked ALS. EMBO Molecular Medicine. 8(12). 1421–1437. 201 indexed citations
13.
Yamanaka, Koji. (2016). The role of microglia in neurodegenerative diseases.
14.
Nakajima, Y., et al.. (2015). A research toward guidance, navigation, and control for a Non-Cooperative Target. JAXA Repository (JAXA). 1 indexed citations
15.
Watanabe, Seiji, et al.. (2014). Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity. Cell Death and Disease. 5(10). e1497–e1497. 64 indexed citations
16.
Nomura, Takao, Shôji Watanabe, Kumi Kaneko, et al.. (2013). Intranuclear Aggregation of Mutant FUS/TLS as a Molecular Pathomechanism of Amyotrophic Lateral Sclerosis. Journal of Biological Chemistry. 289(2). 1192–1202. 109 indexed citations
17.
Cleveland, Don W., Koji Yamanaka, & Pascale Bomont. (2009). Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway. Human Molecular Genetics. 18(8). 1384–1394. 40 indexed citations
18.
Yamanaka, Koji, Séverine Boillée, Elizabeth A. Roberts, et al.. (2008). Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proceedings of the National Academy of Sciences. 105(21). 7594–7599. 232 indexed citations
19.
Boillée, Séverine, Koji Yamanaka, Christian S. Lobsiger, et al.. (2006). Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia. Science. 312(5778). 1389–1392. 1265 indexed citations breakdown →
20.
Yamanaka, Koji. (1997). Rendezvous Strategy of the Japanese Logistics Support Vehicle to the International Space Station. ESASP. 381. 103. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026